These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 12778770
1. [Clinical analysis and long-term follow up study of asymptomatic nasopharyngeal carcinoma patients]. Ji MF, Guo YQ, Zheng SA, Liang JS, Wang DK, Ou XT. Zhonghua Er Bi Yan Hou Ke Za Zhi; 2003 Feb; 38(1):53-6. PubMed ID: 12778770 [Abstract] [Full Text] [Related]
2. [A dynamic study on titer of EB virus VCA/IgA and EA/IgA in nasopharygeal carcinoma patients]. Ji MF, Guo YQ, Liang JS, Zheng SA, Cheng WM, Yu BH, Ou XT, Wang DK. Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):243-5. PubMed ID: 12839685 [Abstract] [Full Text] [Related]
3. [Significance of cell-free Epstein-Barr virus DNA in monitoring prognosis of nasopharyngeal carcinoma]. Cao SM, Min HQ, Gao JS, Hong MH, Xiao XB, Zhang CQ, Liu XD, Zhang AL, Guo X. Ai Zheng; 2003 Mar; 22(3):302-6. PubMed ID: 12654192 [Abstract] [Full Text] [Related]
4. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma. Shao JY, Li YH, Gao HY, Wu QL, Cui NJ, Zhang L, Cheng G, Hu LF, Ernberg I, Zeng YX. Cancer; 2004 Mar 15; 100(6):1162-70. PubMed ID: 15022282 [Abstract] [Full Text] [Related]
7. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia. Karray H, Ayadi W, Fki L, Hammami A, Daoud J, Drira MM, Frikha M, Jlidi R, Middeldorp JM. J Med Virol; 2005 Apr 15; 75(4):593-602. PubMed ID: 15714486 [Abstract] [Full Text] [Related]
12. [Immunoglobulin A serum antibodies against the capsid antigen of Epstein-Barr virus in the differential diagnosis and follow-up of nasopharyngeal cancer]. Pavelka R, Popow-Kraupp T, Radaszkiewicz T. Wien Klin Wochenschr; 1985 Jul 19; 97(14):588-95. PubMed ID: 2996246 [Abstract] [Full Text] [Related]
13. Sensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review. Tsang RK, Vlantis AC, Ho RW, Tam JS, To KF, van Hasselt CA. Head Neck; 2004 Jul 19; 26(7):598-602. PubMed ID: 15229902 [Abstract] [Full Text] [Related]
14. Diagnostic value of Epstein-Barr viral serology in nasopharyngeal carcinoma. Low WK, Leong JL, Goh YH, Fong KW. Otolaryngol Head Neck Surg; 2000 Oct 19; 123(4):505-7. PubMed ID: 11020195 [Abstract] [Full Text] [Related]
15. [Gene engineering EB virus membrane antigen in detection of MA-IgA antibody--comparison with VCA-IgA and EA-IgA antibodies]. Liu MZ. Zhonghua Zhong Liu Za Zhi; 1990 Jul 19; 12(4):288-90. PubMed ID: 2176967 [Abstract] [Full Text] [Related]
16. Epstein-Barr virus seroepidemiology in China. Zeng Y, Pi GH, Deng H, Zhang JM, Wang PC, Wolf H, De Thé G. AIDS Res; 1986 Dec 19; 2 Suppl 1():S7-15. PubMed ID: 3030349 [Abstract] [Full Text] [Related]
17. Serological survey of nasopharyngeal carcinoma in 21 cities of south China. Deng H, Zeng Y, Lei Y, Zhao Z, Wang P, Li B, Pi Z, Tan B, Zheng Y, Pan W. Chin Med J (Engl); 1995 Apr 19; 108(4):300-3. PubMed ID: 7789220 [Abstract] [Full Text] [Related]
18. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma. Paramita DK, Fachiroh J, Artama WT, van Benthem E, Haryana SM, Middeldorp JM. J Med Virol; 2007 Nov 19; 79(11):1710-21. PubMed ID: 17854043 [Abstract] [Full Text] [Related]
19. [Significance of detection of serum sialic acid and Epstein-Barr virus VCA-IgA in diagnosis and monitoring radiotherapy effectiveness in nasopharyngeal carcinoma patients]. Jiang LN, Dai LC, He JF, Chen YW, Ma ZH. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun 19; 20(2):30-2. PubMed ID: 16816858 [Abstract] [Full Text] [Related]